Coronavirus, gold wage increase for astrazeneca’s czeo: is polemic

Coronavirus, gold wage increase for astrazeneca's czeo: is polemic

An increase that not a few shareholders consider more than deserved, numbers and perspectives to the hand, but that does not find unanimity of consents in the financial district of London. Other counselling groups have expressed concern in turn, underlining how – due to the health emergency – more than half of the managers of companies listed in ftse100 saw their salaries frozen for 2021. However, the successes achieved by soriot, even before the pandemic, from its arrival in 2012 to the head of astrazeneca, and the growth of turnover of 11% (7.32 billion dollars) in the last 12 months.

“The money is worth all of them,” he cut short at times among other Samuel Johar, president of buchanan harvey.